LIGAND PHARMACEUTICALS INCORPORATED Debt Instrument, Convertible, Conversion Ratio
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Debt Instrument, Convertible, Conversion Ratio of 1332.51% for the 1-month period ending 2014-08-31, per its 10-Q filed 2017-11-09.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleConversionRatio1 · last filed 2017-11-09
- 2014-08-31: Debt Instrument, Convertible, Conversion Ratio 1 month 1332.51%.
| Period end | Debt Instrument, Convertible, Conversion Ratio 1 month |
|---|---|
| 2014-08-31 | 1332.51% 10-Q · filed 2017-11-09 |